New research shows improvement in components of reading, including decoding and vocabulary, among children treated with atomoxetine compared to a placebo. This new treatment was also associated with significant reductions in symptoms of attention-deficit/hyperactivity disorder in children with both dyslexia and ADHD or ADHD alone, as reported in the study published in Journal of Child and Adolescent Psychopharmacology.
Medical research and medicine are one more way researchers have found to assist those with dyslexia.
There are new treatments for ADHD proven by using placebos.
The study which was conducted at the University of North Carolina by DR. Steven Hooper at the School of Medicine evaluated reading ability and ADHD symptoms in children aged 10-16 years who had dyslexia or ADHD, or only ADHD and received either atomoxetine or placebo for 16 weeks. The authors report their results in the article “Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Co morbid Dyslexia in a Randomized, Placebo-Controlled Trial.
Treatments for dyslexia are essential for the millions of children who suffer from this disorder. This unique study offers a potential promising psychopharmacological intervention for the treatment of dyslexia,” says Harold S. Koplewicz, MD, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology and President of the Child Mind Institute in New York.
Laura Lurns · Learning Success expert
Key takeaways
- Recent research suggests that medication may help dyslexics.
- 10-16 years old were examined in the college study.
- Treatment is crucial for dyslexics.
See MTSS for schools
Is your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.
